Chiesi Farmaceutici SpA is buying the shares of Cornerstone Therapeutics Inc. that it does not already own.

The purchase price works out to $9.50 per share, valuing Cornerstone at about $255 million. Chiesi currently owns 58 percent of the Cary, N.C.-based pharmaceutical company.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.